Avastin Experience Clarifies FDA Concerns With Cooperative Group Trials

FDA's concern with oncologic trials conducted by cooperative groups appears to be focused on the use of progression-free survival as an endpoint, according to Genentech Product Development President Susan Desmond-Hellman